SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

SVB Leerink Reiterates Outperform on AtriCure, Raises Price Target to $55

SVB Leerink reiterates AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $50 to $55.

Benzinga · 05/11/2020 10:16

SVB Leerink reiterates AtriCure (NASDAQ:ATRC) with a Outperform and raises the price target from $50 to $55.